↓ Skip to main content

American College of Cardiology

Article Metrics

Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus

Overview of attention for article published in JACC: Heart Failure, October 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#34 of 723)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
151 tweeters
facebook
2 Facebook pages

Readers on

mendeley
15 Mendeley
Title
Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus
Published in
JACC: Heart Failure, October 2018
DOI 10.1016/j.jchf.2018.05.020
Pubmed ID
Authors

Abhinav Sharma, Lauren B. Cooper, Mona Fiuzat, Robert J. Mentz, João Pedro Ferreira, Javed Butler, David Fitchett, Alan Charles Moses, Christopher O’Connor, Faiez Zannad

Abstract

There is increasing recognition of the relationship between diabetes and heart failure (HF). Comorbid diabetes is associated with worse outcomes in patients with HF, and death from HF forms a large burden of mortality among patients with diabetes and atherosclerotic cardiovascular disease. However, there is evidence of harm relating to the risk of HF outcomes from several antihyperglycemic therapies. The absence of well-powered randomized controlled studies has resulted in significant treatment variations in the glycemic management in patients with coexisting diabetes and HF. However, there is emerging evidence from recent clinical trials suggesting that sodium-glucose-co-transporter-2 inhibitors may be used as a therapy to improve HF outcomes. In order to understand the current state of knowledge, we reviewed the evolving evidence of antihyperglycemic therapies and present strategies to optimize these therapies in patients with diabetes and HF. This analysis is based on discussions among scientists, clinical trialists, industry sponsors, and regulatory representatives who attended the 12th Global Cardiovascular Clinical Trialists Forum, Washington DC, December 1 to 3, 2016.

Twitter Demographics

The data shown below were collected from the profiles of 151 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Poland 1 7%
Unknown 14 93%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 13%
Student > Doctoral Student 2 13%
Student > Bachelor 2 13%
Other 2 13%
Researcher 2 13%
Other 4 27%
Unknown 1 7%
Readers by discipline Count As %
Medicine and Dentistry 7 47%
Unspecified 5 33%
Chemistry 1 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Unknown 1 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 87. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 October 2018.
All research outputs
#159,025
of 12,342,443 outputs
Outputs from JACC: Heart Failure
#34
of 723 outputs
Outputs of similar age
#7,458
of 262,790 outputs
Outputs of similar age from JACC: Heart Failure
#2
of 24 outputs
Altmetric has tracked 12,342,443 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 723 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.3. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 262,790 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.